Study2016Industry funded

Funded in part by Meat and Livestock Australia

Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid

Markworth JF, Kaur G, Miller EG, Larsen AE, Sinclair AJ, Maddipati KR, Cameron-Smith D

FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 75 citations

Review labels

Industry fundedMechanisms only

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design
Randomized controlled trial (classified by our AI screen)
Studied in
People
Main outcome
Mechanisms only

Who paid for it

Funding
Industry funded
Industry group
Meat and Livestock Australia
Government
National Institutes of Health
Government
National Center for Research Resources
Government
NCRR NIH HHS
Grants
National Center for Research Resources (S10-RR-027926)

Based on 4 listed funder(s).

Publication

Published
2016-07-26 · FASEB J · vol. 30 · issue 11 · pp. 3714–3725
Publisher
Wiley
Cited
88 citations · more than 99% of similar papers · 10.7× the field average
Impact
Top 10% most cited in its field
References
75 works
Access
Open access (repository copy)
Research areas
Fatty Acid Research and Health · Eicosanoids and Hypertension Pharmacology · Lipid metabolism and biosynthesis
Keywords
Docosapentaenoic acid, Eicosapentaenoic acid, Docosahexaenoic acid, Polyunsaturated fatty acid, Chemistry, Lipid signaling, Biochemistry, Fatty acid, Lipidomics, Food science, Enzyme
MeSH
humans, fatty acids, omega-3, eicosapentaenoic acid, fatty acids, fatty acids, unsaturated, diet, cross-over studies, dietary supplements, adult, female, lipid metabolism, young adult

7 authors

From NZ, AU, US

  • James F. Markworth · correspondingUniversity of Auckland
  • Gunveen KaurDeakin University
  • Eliza G. MillerDeakin University
  • Amy LarsenLa Trobe University
  • Andrew James SinclairDeakin University
  • Krishna Rao MaddipatiWayne State University; The Barbara Ann Karmanos Cancer Institute

Abstract

In contrast to the well-characterized effects of specialized proresolving lipid mediators (SPMs) derived from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), little is known about the metabolic fate of the intermediary long-chain (LC) n-3 polyunsaturated fatty acid (PUFA) docosapentaenoic acid (DPA). In this double blind crossover study, shifts in circulating levels of n-3 and n-6 PUFA-derived bioactive lipid mediators were quantified by an unbiased liquid chromatography-tandem mass spectrometry lipidomic approach. Plasma was obtained from human subjects before and after 7 d of supplementation with pure n-3 DPA, n-3 EPA or placebo (olive oil). DPA supplementation increased the SPM resolvin D5n-3DPA (RvD5n-3DPA) and maresin (MaR)-1, the DHA vicinal diol 19,20-dihydroxy-DPA and n-6 PUFA derived 15-keto-PG E2 (15-keto-PGE2). EPA supplementation had no effect on any plasma DPA or DHA derived mediators, but markedly elevated monohydroxy-eicosapentaenoic acids (HEPEs), including the e-series resolvin (RvE) precursor 18-HEPE; effects not observed with DPA supplementation. These data show that dietary n-3 DPA and EPA have highly divergent effects on human lipid mediator profile, with no overlap in PUFA metabolites formed. The recently uncovered biologic activity of n-3 DPA docosanoids and their marked modulation by dietary DPA intake reveals a unique and specific role of n-3 DPA in human physiology.-Markworth, J. F., Kaur, G., Miller, E. G., Larsen, A. E., Sinclair, A. J., Maddipati, K. R., Cameron-Smith, D. Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.

Abstract via Europe PMC. Copyright remains with the authors or publisher.

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.